Science

New guideline recognises anti-PLA2R as a significant biomarker for membranous nephropathy

In October 2021, the organisation KDIGO (Kidney Disease: Improving Clinical Outcomes) published an updated version of the clinical guideline for the management of patients with glomerulonephritis. This guideline contains recommendations for diagnostics in primary membranous nephropathy, an autoimmune kidney disease that is characterised in most cases by the occurrence of autoantibodies against PLA2R and/or THSD7A. The […]

Products

T cells: Important building blocks of immune protection against SARS-CoV-2

It is becoming increasingly clear that not only antibodies against SARS-CoV-2 play a role in building immunity against the coronavirus. T cells, as part of the cellular immune response, also have a major function in the development of immune memory to SARS-CoV-2. Findings from research into immunity to related viruses such as SARS-CoV-1 and MERS-CoV (Middle-East respiratory syndrome coronavirus) have shown that cellular immune responses against these coronaviruses

Products

The flu season is getting started

After a virtually non-existent flu season in 2020/2021 and with the revival of public life and the relaxation of social distancing measures, there is increasing concern that a large flu wave could occur in 2021/2022. It cannot be predicted if or how the missing flu season will affect the coming one, but the Robert Koch

Science

Corona is giving a boost to mycology

Guest contribution: Article series on the subject of state-of-the-art mycology in dermatology, 9th article by Prof Hans-Jürgen Tietz, Director of the Institute of Fungal Diseases in Berlin, Germany Recently, a patient said goodbye to me with the words: “If we are not successful with the culture, then I want the genetic test. My health insurance

Company

New partnership: IDS and EUROIMMUN

We are delighted to welcome Immunodiagnostic Systems Holding (IDS) as the newest member of the PerkinElmer family. The acquisition of the British diagnostics company was officially closed in July 2021. In future, IDS and EUROIMMUN will closely cooperate in the fields of research and development, production as well as distribution. IDS is a leading company

Scroll to Top